Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration

Chan, Pak; Heatherly, Kathy; Kupiec, Thomas C; Trissel, Lawrence A

Abstract

Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration

Author(s): Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A

Issue: May/Jun 2008 - Pain Management

View All Articles in Issue

Page(s): 276-278

Download in electronic PDF format for $75

Abstract

The physical compatibility of caspofungin acetate injection with selected other drugs during simulated Y-site coadministration was evaluated by visual observation and turbidity measurement. Five-milliliter samples of caspofungin acetate 0.7 mg/mL in 0.9% sodium chloride injection were combined with 5 mL of 67 other drugs including antineoplastics, analgesics, anti-infectives, and supportive care drugs, undiluted or diluted in 0.9% sodium chloride injection or 5% dextrose injection, and with a parenteral nutrition admixture. Visual examinations were performed with the unaided eye in normal laboratory fluorescent light and with a Tyndall beam (high-intensity monodirectional light beam) to enhance visualization of small particles and low-level turbidity. The turbidity of each sample was measured as well. The sample mixtures were evaluated immediately and at 1 and 4 hours after preparation. Nineteen of the drugs tested and the parenteral nutrition admixture were incompatible with caspofungin acetate 0.7 mg/mL dur

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
May/Jun 2008 Pg. 276-278	Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration Author(s): Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A
Jul/Aug 2002 Pg. 311-315	Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs Author(s): Trissel Lawrence A, Saenz Christopher
Jan/Feb 2001 Pg. 69-73	Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs Author(s): Trissel Lawrence A, Williams Kimberly Y, Baker Ma
Mar/Apr 2008 Pg. 156-160	Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration Author(s): Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Mar/Apr 2008 Pg. 170-173	Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration Author(s): Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A
Jan/Feb 2021 Pg. 52-61	Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration Author(s): Lu Juan, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
Jan/Feb 2009 Pg. 78-80	Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration Author(s): Trissel Lawrence A, Trusley Craig, Kupiec Thomas C, Ben Michel
Nov/Dec 2007 Pg. 520-524	Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2006 Pg. 230-233	Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration Author(s): Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Jul/Aug 2001 Pg. 314-319	Incompatibilities of Lansoprazole Injection with Other Drugs During Simulated Y-Site Coadministration Author(s): Trissel Lawrence A, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S
Jul/Aug 2016 Pg. 328-332	Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures Author(s): Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE
May/Jun 1999 Pg. 241-244	Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration Author(s): Trissel Lawrence A, Gilbert Doward L, Wolkin Allan C
May/Jun 2002 Pg. 230-233	Compatibility Screening of Precedex During Simulated Y-Site Administration with Other Drugs Author(s): Trissel Lawrence A, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S, Retzinger Julie P
Mar/Apr 2025 Pg. 121	Erratum - Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration Author(s):
Jul/Aug 2008 Pg. 368-371	Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Sep/Oct 2013 Pg. 436-438	Compatibility of Amiodarone Hydrochloride with Vasopressin During Simulated Y-site Administration Author(s): Ramaley Corrine C, Li Feng, Du Chengan
May/Jun 2016 Pg. 236-238	Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration Author(s): Mody Vicky, Shah Samit, Patel Jaymin, Thomas Michael C
Jul/Aug 1998 Pg. 318-321	Compatibility and Stability of Ranitidine Hydrochloride with Six Cephalosporins During Simulated Y-Site Administration Author(s): Inagaki Kazuhiro, Kambara Motoya, Mizuno Munemichi, Gill Mark A, Nishida Mikio
Jan/Feb 2012 Pg. 82-85	Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration Author(s): Zhang Yang, Scarlett Cameron, Hutson Paul
Jul/Aug 1999 Pg. 303	Parenteral Admixture with Y-Site Administration Author(s): Allen Loyd V Jr